Romidepsin induces durable responses in patients with relapsed or refractory angioimmunoblastic T‐cell lymphoma

Detalles Bibliográficos
Autores principales: Pro, Barbara, Horwitz, Steven M., Prince, H. Miles, Foss, Francine M., Sokol, Lubomir, Greenwood, Matthew, Caballero, Dolores, Morschhauser, Franck, Wilhelm, Martin, Iyer, Swaminathan Padmanabhan, Shustov, Andrei R., Wolfson, Julie, Balser, Barbara E., Coiffier, Bertrand
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2016
Materias:
Letters to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5763404/
https://www.ncbi.nlm.nih.gov/pubmed/27402335
http://dx.doi.org/10.1002/hon.2320

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5763404/
https://www.ncbi.nlm.nih.gov/pubmed/27402335
http://dx.doi.org/10.1002/hon.2320

Ejemplares similares